Both Met(109) and Met(112) are utilized for Cu(II) coordination by the amyloidogenic fragment of the human prion protein at physiological pH.
The prion protein is a ubiquitous neuronal membrane protein. Misfolding of the prion protein has been implicated in transmissible spongiform encephalopathies (prion diseases). It has been demonstrated that the human prion protein (PrP) is capable of coordinating at least five Cu(II) ions under physiological conditions; four copper binding sites can be found in the octarepeat domain between residues 61 and 91, while another copper binding site can be found in the unstructured "amyloidogenic" domain between residues 91 and 126 PrP(91-126). Herein we expand upon a previous study [J. Shearer, P. Soh, Inorg. Chem. 46 (2007) 710-719] where we demonstrated that the physiologically relevant high affinity Cu(II) coordination site within PrP(91-126) is found between residues 106 and 114. It was shown that Cu(II) is contained within a square planar (N/O)3S coordination environment with one His imidazole ligand (H(111)) and one Met thioether ligand (either M(109) or M(112)). The identity of the Met thioether ligand was not identified in that study. In this study we perform a detailed investigation of the Cu(II) coordination environment within the PrP fragment containing residues 106-114 (PrP(106-114)) involving optical, X-ray absorption, EPR, and fluorescence spectroscopies in conjunction with electronic structure calculations. By using derivatives of PrP(106-114) with systematic Met-->Ile "mutations" we show that the CuII coordination environment within PrP(106-114) is actually comprised of a mixture of two major species; one Cu(II)(N/O)3S center with the M(109) thioether coordinated to CuII and another CuII(N/O)3S center with the M(112) thioether coordinated to CuII. Furthermore, deletion of one or more Met residues from the primary sequence of PrP(106-114) both reduces the CuII affinity of the peptide by two to seven fold, and renders the resulting CuII metallopeptides redox inactive. The biological implications of these findings are discussed.
Shearer
Jason
J
Department of Chemistry/216, University of Nevada, 1664 N. Virginia St. Reno, NV 89503-0216, USA. shearer@unr.edu
Soh
Pamela
P
Lentz
Stefanie
S
D000595:Amino Acid Sequence; D000682:Amyloid / Q000737:chemistry / Q000378:metabolism*; D000818:Animals; D001665:Binding Sites; D003300:Copper / Q000378:metabolism*; D006801:Humans; D008969:Molecular Sequence Data; D010455:Peptides / Q000138:chemical synthesis / Q000737:chemistry / Q000378:metabolism*; D011328:Prions / Q000737:chemistry / Q000378:metabolism*; D017434:Protein Structure, Tertiary; D016415:Sequence Alignment
D000682:Amyloid; D010455:Peptides; D011328:Prions; D003300:Copper
Biochem J. 2007 Jun 15;404(3):393-402
17331076
Genome Res. 1998 Oct;8(10):1022-37
9799790
Chembiochem. 2003 Dec 5;4(12):1268-84
14661267
Gene. 2004 Oct 27;341:249-53
15474307
J Am Chem Soc. 2005 Apr 20;127(15):5449-62
15826182
Nature. 2004 Aug 26;430(7003):977-9
15329705
Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13363-83
9811807
Acc Chem Res. 2004 Feb;37(2):79-85
14967054
Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8531-5
11438695
J Mol Biol. 2005 Mar 11;346(5):1393-407
15713489
Phys Rev A Gen Phys. 1988 Sep 15;38(6):3098-3100
9900728
Science. 2002 Jun 14;296(5575):1991-5
12065827
Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):651-5
15647366
Biochemistry. 2006 Oct 31;45(43):13083-92
17059225
Chem Rev. 2006 Jun;106(6):1995-2044
16771441
Cell. 2005 Apr 22;121(2):195-206
15851027
Inorg Chem. 2005 Oct 3;44(20):7214-25
16180886
J Clin Neurosci. 2001 Sep;8(5):387-97
11535002
Phys Rev B Condens Matter. 1988 Jan 15;37(2):785-789
9944570
Phys Rev B Condens Matter. 1986 Jun 15;33(12):8822-8824
9938299
Inorg Chem. 2006 Dec 11;45(25):10098-107
17140215
Phys Rev A. 1994 Apr;49(4):2421-2431
9910514
Alzheimer Dis Assoc Disord. 2002;16 Suppl 1:S1-8
12070355
Biochemistry. 1998 May 19;37(20):7185-93
9585530
J Biol Inorg Chem. 2006 Sep;11(6):702-11
16821037
Curr Opin Chem Biol. 2003 Feb;7(1):125-35
12547437
J Biol Chem. 2004 Jul 30;279(31):32018-27
15145944
Biochemistry. 2003 Jun 10;42(22):6794-803
12779334
Biochemistry. 2004 Apr 20;43(15):4439-46
15078089
J Mol Biol. 2001 Aug 17;311(3):467-73
11493001
Science. 1997 Oct 10;278(5336):245-51
9323196
Arch Biochem Biophys. 1974 Dec;165(2):691-708
4374138
J Biol Chem. 1998 Dec 11;273(50):33107-10
9837873
Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15137-42
10611351
Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2042-7
10051591
Phys Rev B Condens Matter. 1986 Nov 15;34(10):7406
9949100
Chemistry. 2000 Nov 17;6(22):4195-202
11128284
Inorg Chem. 2007 Feb 5;46(3):710-9
17257012
Inorg Chem. 2003 Aug 11;42(16):4790-1
12895095
Nature. 1997 Dec 18-25;390(6661):684-7
9414160
Biochemistry. 2001 Mar 6;40(9):2743-53
11258885
J Biol Chem. 2002 Jun 14;277(24):21140-8
11912192
Science. 1982 Apr 9;216(4542):136-44
6801762